• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白寡聚体中的多态性及其在疾病状态下的毒性影响。

Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions.

作者信息

Yoo Je Min, Lin Yuxi, Heo Yunseok, Lee Young-Ho

机构信息

BioGraphene Inc, Los Angeles, CA, United States.

Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, South Korea.

出版信息

Front Mol Biosci. 2022 Aug 12;9:959425. doi: 10.3389/fmolb.2022.959425. eCollection 2022.

DOI:10.3389/fmolb.2022.959425
PMID:36032665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412080/
Abstract

The major hallmark of Parkinson's disease (PD) is represented by the formation of pathological protein plaques largely consisting of α-synuclein (αSN) amyloid fibrils. Nevertheless, the implications of αSN oligomers in neuronal impairments and disease progression are more importantly highlighted than mature fibrils, as they provoke more detrimental damages in neuronal cells and thereby exacerbate α-synucleinopathy. Interestingly, although generation of oligomeric species under disease conditions is likely correlated to cytotoxicity and different cellular damages, αSN oligomers manifest varying toxicity profiles dependent on the specific environments as well as the shapes and conformations the oligomers adopt. As such, this minireview discusses polymorphism in αSN oligomers and the association of the underlying heterogeneity in regard to toxicity under pathological conditions.

摘要

帕金森病(PD)的主要标志是形成主要由α-突触核蛋白(αSN)淀粉样原纤维组成的病理性蛋白质斑块。然而,αSN寡聚体在神经元损伤和疾病进展中的影响比成熟原纤维更受关注,因为它们在神经元细胞中引发更有害的损伤,从而加剧α-突触核蛋白病。有趣的是,尽管在疾病条件下寡聚体的产生可能与细胞毒性和不同的细胞损伤相关,但αSN寡聚体表现出不同的毒性特征,这取决于特定的环境以及寡聚体所采用的形状和构象。因此,本综述讨论了αSN寡聚体的多态性以及病理条件下潜在异质性与毒性的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/9412080/81235d5015ca/fmolb-09-959425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/9412080/f24ee7cdeedf/fmolb-09-959425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/9412080/81235d5015ca/fmolb-09-959425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/9412080/f24ee7cdeedf/fmolb-09-959425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/9412080/81235d5015ca/fmolb-09-959425-g002.jpg

相似文献

1
Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions.α-突触核蛋白寡聚体中的多态性及其在疾病状态下的毒性影响。
Front Mol Biosci. 2022 Aug 12;9:959425. doi: 10.3389/fmolb.2022.959425. eCollection 2022.
2
Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.橄榄果提取物中的橄榄苦苷衍生物可减少α-突触核蛋白的纤维形成和寡聚毒性。
J Biol Chem. 2019 Mar 15;294(11):4215-4232. doi: 10.1074/jbc.RA118.005723. Epub 2019 Jan 17.
3
Co-existence of two different α-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry.两种具有不同核心结构的α-突触核蛋白寡聚物的共存通过氢/氘交换质谱法确定。
Angew Chem Int Ed Engl. 2014 Jul 14;53(29):7560-3. doi: 10.1002/anie.201400491. Epub 2014 Apr 16.
4
High stability and cooperative unfolding of α-synuclein oligomers.α-突触核蛋白寡聚体的高稳定性与协同解折叠
Biochemistry. 2014 Oct 7;53(39):6252-63. doi: 10.1021/bi5007833. Epub 2014 Sep 24.
5
Citrus Flavonoid Hesperetin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Reduces Their Cytotoxicity: In Vitro and In Vivo Studies.柑橘类黄酮橙皮素抑制α-突触核蛋白纤维形成,破坏成熟纤维,并降低其细胞毒性:体外和体内研究
J Agric Food Chem. 2023 Nov 1;71(43):16174-16183. doi: 10.1021/acs.jafc.3c06816. Epub 2023 Oct 23.
6
Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.使用质谱监测的氢/氘交换来描述α-突触核蛋白寡聚物的动力学。
Biochemistry. 2013 Dec 23;52(51):9097-103. doi: 10.1021/bi4009193. Epub 2013 Dec 11.
7
The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.α-突触核蛋白的 N 端对于单体和寡聚体与膜的相互作用都是必需的。
FEBS Lett. 2014 Jan 31;588(3):497-502. doi: 10.1016/j.febslet.2013.12.015. Epub 2013 Dec 25.
8
How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.没食子儿茶素没食子酸酯结合和组装人α-突触核蛋白的寡聚形式。
J Biol Chem. 2021 Jan-Jun;296:100788. doi: 10.1016/j.jbc.2021.100788. Epub 2021 May 18.
9
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.稳定的α-突触核蛋白寡聚体在淀粉样形成的分子事件中的作用。
J Am Chem Soc. 2014 Mar 12;136(10):3859-68. doi: 10.1021/ja411577t. Epub 2014 Feb 28.
10
Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity.二氢杨梅素抑制α-突触核蛋白聚集、破坏原纤维,并保护培养的神经元细胞免受淀粉样蛋白诱导的细胞毒性。
J Agric Food Chem. 2019 Apr 10;67(14):3946-3955. doi: 10.1021/acs.jafc.9b00922. Epub 2019 Mar 29.

引用本文的文献

1
Alpha Synuclein Toxicity and Non-Motor Parkinson's.α-突触核蛋白毒性与非运动性帕金森病
Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265.
2
Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site.α-突触核蛋白二聚体的初级成核取决于铜浓度和明确的铜结合位点。
Biomolecules. 2024 May 26;14(6):627. doi: 10.3390/biom14060627.
3
Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson's Disease.评估唾液和皮肤生物标志物联合在帕金森病中的诊断潜力。

本文引用的文献

1
Dual Effects of Presynaptic Membrane Mimetics on -Synuclein Amyloid Aggregation.突触前膜模拟物对α-突触核蛋白淀粉样聚集的双重作用。
Front Cell Dev Biol. 2022 Jun 7;10:707417. doi: 10.3389/fcell.2022.707417. eCollection 2022.
2
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.α-突触核蛋白寡聚体中的病理性 G51D 突变赋予其独特的结构特征和细胞毒性。
Molecules. 2022 Feb 15;27(4):1293. doi: 10.3390/molecules27041293.
3
Molecular insights into α-synuclein interaction with individual human core histones, linker histone, and dsDNA.
Int J Mol Sci. 2024 Apr 28;25(9):4823. doi: 10.3390/ijms25094823.
4
4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications.4-氧代-2-壬烯醛诱导的α-突触核蛋白和磷酸化α-突触核蛋白聚集体具有不同的生物物理特性和生物医学应用。
Cells. 2024 Apr 24;13(9):739. doi: 10.3390/cells13090739.
5
Development of fluorophores for the detection of oligomeric aggregates of amyloidogenic proteins found in neurodegenerative diseases.用于检测神经退行性疾病中发现的淀粉样蛋白寡聚聚集体的荧光团的开发。
Front Chem. 2023 Dec 22;11:1343118. doi: 10.3389/fchem.2023.1343118. eCollection 2023.
6
Synucleinopathies: Intrinsic and Extrinsic Factors.突触核蛋白病:内在和外在因素。
Cell Biochem Biophys. 2023 Sep;81(3):427-442. doi: 10.1007/s12013-023-01154-z. Epub 2023 Aug 1.
7
Glucagon-like peptide 1 aggregates into low-molecular-weight oligomers off-pathway to fibrillation.胰高血糖素样肽 1 聚集形成低分子量寡聚体,偏离纤颤途径。
Biophys J. 2023 Jun 20;122(12):2475-2488. doi: 10.1016/j.bpj.2023.04.027. Epub 2023 May 2.
8
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.一种基于通过KEAP1/NRF2激活转录基因来开发新的抗氧化疗法的帕金森病临床前模型。
Antioxidants (Basel). 2023 Mar 9;12(3):673. doi: 10.3390/antiox12030673.
9
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases.突触核蛋白:关于错误折叠、聚集及在疾病中作用的新数据
Biomedicines. 2022 Dec 13;10(12):3241. doi: 10.3390/biomedicines10123241.
10
Distribution, Function, and Expression of the Apelinergic System in the Healthy and Diseased Mammalian Brain.阿片肽能系统在健康和患病哺乳动物大脑中的分布、功能和表达。
Genes (Basel). 2022 Nov 21;13(11):2172. doi: 10.3390/genes13112172.
α-突触核蛋白与人类核心组蛋白、连接组蛋白和 dsDNA 相互作用的分子见解。
Protein Sci. 2021 Oct;30(10):2121-2131. doi: 10.1002/pro.4167. Epub 2021 Aug 19.
4
Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers.鲨胺及其衍生物调节β-淀粉样蛋白和α-突触核蛋白的聚集并抑制其寡聚体的毒性。
Front Neurosci. 2021 Jun 18;15:680026. doi: 10.3389/fnins.2021.680026. eCollection 2021.
5
The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells.α-突触核蛋白纤维中有毒寡聚物的释放会导致神经元细胞功能障碍。
Nat Commun. 2021 Mar 22;12(1):1814. doi: 10.1038/s41467-021-21937-3.
6
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.淀粉样寡聚体:阿尔茨海默病、帕金森病、2 型糖尿病和肌萎缩侧索硬化症的联合实验/计算研究视角。
Chem Rev. 2021 Feb 24;121(4):2545-2647. doi: 10.1021/acs.chemrev.0c01122. Epub 2021 Feb 5.
7
Identification of on- and off-pathway oligomers in amyloid fibril formation.淀粉样纤维形成过程中“on-pathway”和“off-pathway”寡聚体的鉴定。
Chem Sci. 2020 Jun 8;11(24):6236-6247. doi: 10.1039/c9sc06501f. eCollection 2020 Jun 28.
8
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.阿杜卡奴单抗、根特纳单抗、BAN2401 和 ALZ-801——用于治疗阿尔茨海默病的首批靶向淀粉样蛋白药物,具有近期获批的潜力。
Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.
9
Structural mapping of oligomeric intermediates in an amyloid assembly pathway.淀粉样蛋白组装途径中寡聚中间体的结构映射。
Elife. 2019 Sep 25;8:e46574. doi: 10.7554/eLife.46574.
10
α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.α-突触核蛋白寡聚物和纤维:种类繁多,毒性各异。
J Neurochem. 2019 Sep;150(5):522-534. doi: 10.1111/jnc.14808. Epub 2019 Aug 2.